The Bank of Japan is standing pat on its yield curve control policy, and that’s reverberating throughout global markets. We’ll drill down on the decline in the dollar, and the stocks poised to benefit here.
Plus, Moderna’s RSV vaccine efficacy is driving the stock higher, and setting the stage for a new post-Covid battleground. We’ll speak to an analyst who says this could be a game changer for $MRNA shares.
And, the U.S. is poised to hit its debt ceiling tomorrow, much sooner than expected. And a showdown in Washington could come at a high cost. We’ll look at the potential fallout for markets & the economy.
Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
The Exchange